Bodhi Tree Biotechnology (BDTB) EBITDA (2024 - 2025)
Bodhi Tree Biotechnology (BDTB) reported EBITDA of -$52949.0 for Q4 2025, up 18.26% year-over-year from -$44773.5 in Q4 2024, and down 395.45% on a QoQ basis from -$10687.0 in Q3 2025.
Bodhi Tree Biotechnology (BDTB) has 2 years of EBITDA data on file, last reported at -$52949.0 in Q4 2025.
- Quarterly EBITDA rose 18.26% year-over-year to -$52949.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$137838.0 (changed N/A YoY) and the FY2025 annual result came in at -$147618.0, down 138.27% from the prior year.
- EBITDA fell to -$52949.0 in Q4 2025 per BDTB's latest filing, from -$10687.0 in the prior quarter.
- Across five years, EBITDA topped out at -$10687.0 in Q3 2025 and bottomed at -$64777.0 in Q4 2024.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -52,949.00 |
| Sep 30, 2025 | -10,687.00 |
| Jun 30, 2025 | -20,774.00 |
| Mar 31, 2025 | -53,428.00 |
| Dec 31, 2024 | -64,777.00 |